Assistant Professor, Orthopedics
The Carry Musculoskeletal Epidemiology Lab uses single and multi-omics data to understand the etiology of complex musculoskeletal disease. Through partnerships with clinicians, I aim to translate these epidemiologic research efforts into effective clinical interventions. Another core priority of my lab is to evaluate and develop new orthopedic clinical research methods. My primary research interests include the etiology of adolescent idiopathic scoliosis, concussion, osteoarthritis, and T1D.
Professional Research Assistant, CUIJBP
Andrew Clauw is a professional research assistant with several years of experience managing large human subject trials for chronic pain populations, to include inflammatory arthritis and osteoarthritis. He is interested in supporting research to improve our knowledge of these diseases so that we may better and earlier identify people at risk and provide more informed patient-centric treatments.
Director Bone and Soft Tissue Pathology
Dr. Clay is a dual board certified anatomic and molecular pathologist for the adult and children's hospitals at the University of Colorado Anschutz Medical Campus. He is the director of the bone and soft tissue service at the UCH adult hospital. He also collaborates with the molecular pathology group at the Children's Hospital of Colorado.
Director of the Joint Preservation Program
Associate Professor, Orthopedics
Dr. Frank is a board certified orthopaedic surgeon and sports medicine specialist who focuses on the surgical and non-surgical management of knee, shoulder, and elbow injuries. Currently, Dr. Frank serves as an Associate Professor in Orthopaedic Surgery at the University of Colorado School of Medicine, is Director of the Joint Preservation Program at the University of Colorado, and is team physician for the Colorado Rapids professional soccer team. Dr. Frank has authored or co-authored over 250 peer-reviewed journal articles, over 50 book chapters, and presents her research both nationally and internationally at orthopaedic conferences and meetings every year.
Division Head, Rheumatology
Dr. Holers research group performs both basic and translational research. A longstanding interest has been to decipher the roles of the complement system, including its pathways and effectors, in the immune response, with a special emphasis on developing novel tissue targeted inhibitors for inflammatory and autoimmune diseases. Candidate therapeutics derived from these studies have been advanced to clinical trials in humans. A second area of emphasis is on the natural history of rheumatoid arthritis (RA) with the goal to understand, and then develop methods to interrupt, causal drivers of this disease from the preclinical stage of autoimmunity alone through to the development of inflammatory arthritis.
Assistant Professor, Rheumatology
Dr. Jonsson is a board-certified rheumatologist and Assistant Professor of Medicine who leads a research group focused on CD8 T cells and other granzyme K-expressing cells in rheumatoid arthritis and other types of arthritis and autoimmune diseases. Her lab uses single-cell sequencing and other cutting-edge technologies to study the mechanisms by which CD8 T cells, NK cells, and other lymphocytes contribute to inflammation in arthritis and other tissues.
Visiting Professor, Rheumatology and Orthopedics
Dr. Moreland has been in academics for over 30 years. While a faculty member at the University of Alabama at Birmingham (UAB) (1990 to 2007) he developed the Arthritic Clinical Intervention Program and was lead investigator for many of the early clinical trials with biologics for rheumatoid arthritis (RA). From July 2007 to May 2020 Dr. Moreland was Chief of the Division of Rheumatology and Clinical Immunology at the University of Pittsburgh. He recently joined the University of Colorado faculty in May of 2020.
Program Manager, CUIJBP
Jennifer Seifert is the program manager of several research projects at the University of Colorado, which include the newly-founded CUIJBP and the NIH-sponsored initiative, the Accelerated Medicines Partnership (AMP) in arthritis and lupus research. She received her Master’s degree from the University of Colorado School of Public Health and enjoys employing epidemiologic principles to the study of chronic diseases, specifically, rheumatoid arthritis and type 1 diabetes.